Small Intestinal Bacterial Overgrowth and Pediatric Obesity—A Systematic Review
Nutrients · 2025
DOI: 10.3390/nu17091499 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, 2025. Verfasst von Ana Maria Koller und 2 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Gheorghe Marinescu Street No 38, 5401…. Hauptthemen laut MEDLINE: Pediatric Obesity, Intestine, Small, Gastrointestinal Microbiome, Blind Loop Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Childhood obesity is a growing global concern linked to metabolic disorders such as nonalcoholic fatty liver disease (NAFLD). Small intestinal bacterial overgrowth (SIBO) may exacerbate these conditions by promoting systemic inflammation and metabolic dysfunction. This review evaluates the prevalence of SIBO in obese children, its association with inflammatory and metabolic markers, and the efficacy of diagnostic and therapeutic strategies.
Methods
A systematic search of PubMed, Scopus, and Web of Science (2010–present) was conducted using Boolean operators: (‘small intestinal bacterial overgrowth’ OR ‘SIBO’) AND ‘prevalence’ AND (‘low-grade inflammatory markers’ OR ‘metabolic status’) AND ‘gut microbiome’ AND ‘dysbiosis’ AND ‘obese children’.
Results
The data show that SIBO is frequently observed in obese pediatric populations and is associated with gut dysbiosis, impaired nutrient absorption, and reduced production of short-chain fatty acids. These changes contribute to increased intestinal permeability, endotoxemia, and chronic low-grade inflammation. Several microbial taxa have been proposed as biomarkers and therapeutic targets. Diagnostic inconsistencies persist, but treatments such as probiotics, prebiotics, dietary interventions, and selective antibiotics show potential, pending further validation.
Conclusions
Early identification and treatment of SIBO with tailored strategies may help reduce metabolic complications and improve outcomes in children with obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral School, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Gheorghe Marinescu Street No 38, 540136 Targu Mures, Romania.
- Department of Pediatrics 3, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Gheorghe Marinescu Street No 38, 540136 Targu Mures, Romania.
- Department of Pediatrics 1, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Gheorghe Marinescu Street No 38, 540136 Targu Mures, Romania.
ORCID-Profile: Ana Maria Koller, Maria Oana Săsăran, Cristina Oana Mărginean
Zitieren
APA
Koller, A. M., Săsăran, M. O., & Mărginean, C. O. (2025). Small Intestinal Bacterial Overgrowth and Pediatric Obesity—A Systematic Review. Nutrients. https://doi.org/10.3390/nu17091499
Vancouver
Koller AM, Săsăran MO, Mărginean CO. Small Intestinal Bacterial Overgrowth and Pediatric Obesity—A Systematic Review. Nutrients. 2025. doi:10.3390/nu17091499
BibTeX
@article{Koller2025,
author = {Koller, Ana Maria and Săsăran, Maria Oana and Mărginean, Cristina Oana},
title = {Small Intestinal Bacterial Overgrowth and Pediatric Obesity—A Systematic Review},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17091499}
}
EUVIMED